Skip to main content
SpringerLink
Log in

Interleukin-10

Cytokine Synthesis Inhibitory Factor, SCH 52000, rIL-10, rhIL-10

  • Adis R&D Profile
  • Section 2: Inflammatory Bowel Disorders
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bromberg JS. IL-10 immunosuppression in transplantation. Curr Opin Immunol 1995 Oct; 7: 639–43

    Article  PubMed  CAS  Google Scholar 

  2. Huhn RD, O’Connell SM, Radwanski E, et al. Phase I pharmacodynamic study of intravenous recombinant human interleukin-10 in normal volunteers. Clin Pharmacol Ther 1995 Feb; 57: 162

    Article  Google Scholar 

  3. Huhn RD, Pennline K, Radwanski E, et al. Recombinant human interleukin-10: safety, pharmacodynamics and immunohematologic effects of repeated daily subcutaneous doses in healthy volunteers. Blood 1997 Nov 15; 90 Suppl. 1: 280

    Google Scholar 

  4. Chernoff AE, Granowitz EV, Shapiro L, et al. A randomized, controlled trial of IL-10 in humans: inhibition of inflammatory cytokine production and immune responses. J Immunol 1995 May 15; 154: 5492–9

    PubMed  CAS  Google Scholar 

  5. Wissing KM, Morelon E, Legendre C, et al. A pilot trial of recombinant human interleukin-10 in kidney transplant recipients receiving OKT3 induction therapy. Transplantation 1997 Oct 15; 64: 999–1006

    Article  PubMed  CAS  Google Scholar 

  6. Schreiber S, Fedorak RN, Nielsen OH, et al. A safety and efficacy study of recombinant human interleukin-10 (rHuIL-10) treatment in 329 patients with chronic active Crohn’s disease. Gastroenterology 1998 Apr 15; 114 Suppl. 2: 1080

    Google Scholar 

  7. de Vries JE. Immunosuppressive and anti-inflammatory properties of interleukin 10 [review]. Ann Med 1995 Oct; 27 (5): 537–41

    Article  PubMed  Google Scholar 

  8. Herfarth HH, Böcker U, Janardhanam R, et al. Subtherapeutic corticosteroids potentiate the ability of interleukin 10 to prevent chronic inflammation in rats. Gastroenterology 1998 Oct; 15: 856–65

    Article  Google Scholar 

  9. Van Hogezand RA, Verspaget HW. New therapies for inflammatory bowel disease: an update on chimeric anti-TNF-alpha antibodies and IL-10 therapy. Scand J Gastroenterol 1997; 32 Suppl. 223: 105–7

    Google Scholar 

  10. Schreiber S, Fedorak RN, Wild G, et al. Safety and tolerance of rHuIL-10 treatment in patients with mild/moderate active ulcerative colitis. Gastroenterology 1998 Apr 15; 114 Suppl. 2: 1080–1

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Interleukin-10. Drugs R&D 1, 262–264 (1999). https://doi.org/10.2165/00126839-199901030-00017

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199901030-00017

Keywords

Search

Navigation